We will kick off with a session on Scientific Breakthroughs: Cutting Edge Microbiome Research Amid the Pandemic with immunity, vaccines and COVID-19 at the forefront. This broadcast will feature two high-level presentations from Prof David Lynn, EMBL Australia Group Leader and Program Director, The SAHMRI Precision Medicine Theme, and Prof Siew C NG, Director of Microbiota (ICenter MagIC ) at Hong Kong Science and Technology Park and Associate Director of Centre for Gut Microbiota Research, The Chinese University of Hong Kong. Prof Lynn will be asking ‘Can the microbiota be targeted to enhance immune responses to vaccination?’, while Prof Ng will assess ‘The promise of Microbiota modulation during the COVID 19 pandemic’.
We’ll also have a live and interactive panel debate featuring a host of international experts, as well as extensive networking and group discussion opportunities.
